Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.

Park R, Ping L, Song J, Seo JY, Choi TY, Choi JR, Gorkun OV, Lord ST.

Thromb Haemost. 2013 Feb;109(2):199-206. doi: 10.1160/TH12-08-0609. Epub 2012 Dec 6.

PMID:
23224113
2.

Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.

Park R, Ping L, Song J, Hong SY, Choi TY, Choi JR, Gorkun OV, Lord ST.

Thromb Haemost. 2012 May;107(5):875-83. doi: 10.1160/TH11-10-0731. Epub 2012 Mar 22.

PMID:
22437918
3.

Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.

Soya K, Terasawa F, Okumura N.

Thromb Haemost. 2013 Feb;109(2):221-8. doi: 10.1160/TH12-09-0684. Epub 2012 Dec 13.

PMID:
23238100
4.
6.

Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.

Okumura N, Terasawa F, Fujita K, Fujihara N, Tozuka M, Koh CS.

Thromb Res. 2002 Aug 15;107(3-4):157-62.

PMID:
12431483
7.

Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.

Ishikawa S, Hirota-Kawadobora M, Tozuka M, Ishii K, Terasawa F, Okumura N.

J Thromb Haemost. 2004 Mar;2(3):468-75.

8.

A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking.

Park R, Doh HJ, An SS, Choi JR, Chung KH, Song KS.

Blood. 2006 Sep 15;108(6):1919-24. Epub 2006 May 30.

9.

Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.

Ikeda M, Kobayashi T, Arai S, Mukai S, Takezawa Y, Terasawa F, Okumura N.

Thromb Res. 2014 Aug;134(2):518-25. doi: 10.1016/j.thromres.2014.06.002. Epub 2014 Jun 11.

PMID:
24968960
10.
11.

Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.

Allan P, Uitte de Willige S, Abou-Saleh RH, Connell SD, Ariëns RA.

J Thromb Haemost. 2012 Jun;10(6):1072-80. doi: 10.1111/j.1538-7836.2012.04717.x.

12.

B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.

Okumura N, Terasawa F, Haneishi A, Fujihara N, Hirota-Kawadobora M, Yamauchi K, Ota H, Lord ST.

J Thromb Haemost. 2007 Dec;5(12):2352-9. Epub 2007 Oct 8.

13.

Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).

Mukai S, Ikeda M, Takezawa Y, Sugano M, Honda T, Okumura N.

Thromb Res. 2015 Dec;136(6):1318-24. doi: 10.1016/j.thromres.2015.11.011. Epub 2015 Nov 10.

PMID:
26573395
14.

Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.

Niwa K, Mimuro J, Miyata M, Sugo T, Ohmori T, Madoiwa S, Tei C, Sakata Y.

Thromb Res. 2008;121(6):773-80. Epub 2007 Sep 12.

PMID:
17854865
17.
18.
19.

The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).

Mosesson MW, Siebenlist KR, DiOrio JP, Matsuda M, Hainfeld JF, Wall JS.

J Clin Invest. 1995 Aug;96(2):1053-8.

20.

Alpha-Chain cross-linking in fibrin(ogen) Marburg.

Sobel JH, Trakht I, Wu HQ, Rudchenko S, Egbring R.

Blood. 1995 Aug 1;86(3):989-1000.

Supplemental Content

Support Center